Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Phathom Pharmaceuticals Inc (NQ: PHAT )

11.66 +0.03 (+0.26%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 193,172
Open 11.41
Bid (Size) 10.84 (1)
Ask (Size) 12.02 (1)
Prev. Close 11.63
Today's Range 11.41 - 11.83
52wk Range 5.840 - 14.45
Shares Outstanding 43,614,075
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
From Phathom Pharmaceuticals
Via GlobeNewswire
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation - PHAT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures Product Safety

Performance

YTD
-2.75%
-2.75%
1 Month
+0.34%
+0.34%
3 Month
+33.56%
+33.56%
6 Month
+12.88%
+12.88%
1 Year
+62.40%
+62.40%

More News

Read More
PHATHOM ALERT: Bragar Eagel & Squire, P.C. is Investigating Phathom Pharmaceuticals, Inc. on Behalf of Phathom Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Phathom Pharmaceuticals Resubmits FDA Application For Acid Blocker, Raises $131M Via Equity
Via Benzinga
Analyst Expectations for Phathom Pharmaceuticals's Future
Via Benzinga
Where Phathom Pharmaceuticals Stands With Analysts
Via Benzinga
Where Phathom Pharmaceuticals Stands With Analysts
Via Benzinga
Phathom Pharmaceuticals Announces Pricing of Public Offering of Common Stock
From Phathom Pharmaceuticals
Via GlobeNewswire
Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock
From Phathom Pharmaceuticals
Via GlobeNewswire
Phathom Pharmaceuticals Resubmits Erosive GERD New Drug Application to FDA
From Phathom Pharmaceuticals
Via GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation - PHAT
Via NewMediaWire
Exposures Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2023
Via Benzinga
Phathom Pharmaceuticals Reports First Quarter 2023 Results
From Phathom Pharmaceuticals
Via GlobeNewswire
Phathom Pharmaceuticals Presents New Data at Digestive Disease Week® (DDW) 2023
From Phathom Pharmaceuticals
Via GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation - PHAT
Via NewMediaWire
Exposures Product Safety
Phathom Pharmaceuticals Inc. (NASDAQ: PHAT) Near the Top of Equities by Percentage Gain on 4/13
Via Investor Brand Network
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
From Phathom Pharmaceuticals
Via GlobeNewswire
Insiders Buying Phathom Pharmaceuticals And 2 Other Stocks
Via Benzinga
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation - PHAT
Via NewMediaWire
Exposures Product Safety
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Phathom Pharmaceuticals Announces Regulatory Update and Plans for 2023 Erosive Esophagitis and H. pylori Commercial Launch
From Phathom Pharmaceuticals
Via GlobeNewswire
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 13, 2023
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – PHAT
From The Rosen Law Firm PA
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.